MENS Jyong Biotech Limited Gross Return on Sales

Official company branding of Jyong Biotech Limited (MENS)

Risks for Jyong Biotech Ltd (MENS) are linked to stringent regulatory oversight and potential disruptions during new product launches. Gross margin fluctuations illustrate profitability dynamics, while 0.00 captures the magnitude of this parameter. Business efficiency is bolstered by strong pricing power within the plant-based pharmaceutical niche. A positive trend is supported by growing demand for preventive medicine in Asia.

MENS jyongbio.com: Return on Gross Profit in the range 06/18/2025 - 11/20/2026

Financial and market metric breakdowns for jyongbio.com (MENS)

- stock value and consensus price forecast:
Basic company analysis:MENS Jyong Biotech Corp
Finished products of Jyong Biotech Ltd

Gross margin determines the efficiency of direct production by measuring the profit share of each unit of revenue after deducting all variable costs associated with product creation. An analysis of the annual gross margin allows for an assessment of the internal profitability of Jyong Biotech Ltd (MENS), where the financial result depends not on market conditions, but on the successful completion of clinical trial stages and the procurement of regulatory approvals.

Key competitors

Gross Profit Margin Haleon PLC (HLN)|Return on Gross Profit KVUE|Gross Profit Margin Verona Pharma Inc. VRNA|Gross Profitability Ligand (LGND)|Gross Margin amneal.com (AMRX)|Gross Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Gross Profit Margin|Liquidia Inc. - Gross Margin|Gross Sales Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Gross Profitability|Gross Return on Sales MNKD|Gross Profitability Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Return on Sales by Gross Profit|Gross Margin SPRY|TBPH - Gross Profit Margin|Aquestive Pharma - Return on Gross Profit|Gross Margin scpharmaceuticals.com SCPH|Tectonic - Gross Margin|TNXP - Gross Margin|SXTC: Gross Margin|Eupraxia Pharma - Gross Profit Rate|BHST (bioharvest.com) - Gross Margin|Gross Return on Sales EXOZ (invizyne.com)|Gross Margin ORMP|Return on Sales by Gross Profit Entera Bio|Gross Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Gross Profitability|Cumberland Corp - Gross Margin|QNTM - Gross Margin|FibroGen, Inc. (FGEN) - Gross Profitability|TELO: Gross Profit Ratio|RANI (Rani Therapeutics Inc) - Gross Margin|Gross Profit Margin synergychc.com SNYR|Gross Profitability Rallybio Corp. (RLYB)|LEXX - Gross Profit Margin|Gross Margin PULM (pulmatrix.com)|Gross Profit Ratio PTHL (Pheton)|APM - Gross Profitability|Return on Sales by Gross Profit Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Gross Profitability|TNF Pharma (TNFA) - Gross Margin|YCBD (cbdmd.com) - Gross Margin|Return on Gross Profit PainReform (PRFX)|Gross Profitability Altamira Therapeutics (CYTO)|Return on Sales by Gross Profit Lipella Pharma|Optinose - Return on Gross Profit|Return on Sales by Gross Profit pieris.com (PIRS)|PROC - Gross Profitability|Gross Profitability Margin PTPI|QLI: Gross Margin|Gross Profit Margin ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Gross Margin